102Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Czechia
Neuroscience Intelligence
Czechia neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #25 of 50 · Data maturity A · Research score 35.7 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
26Recruiting trials
31Publications
39Institutions
Executive interpretation
Czechia ranks #25 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC75 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.40 recruiting
Boehringer Ingelheim40 recruiting
Masaryk University41 recruiting
UCB Pharma40 recruiting
Novo Nordisk A/S30 recruiting
Ipsen32 recruiting
Eisai Limited30 recruiting
Biogen31 recruiting
AbbVie30 recruiting
Disease activity
Parkinsons18trials
Epilepsy18trials
Alzheimers9trials
Multiple Sclerosis7trials
Other Neurology6trials
Pain Neuropathy4trials
Stroke4trials
Depression3trials
Migraine Headache3trials
Bipolar Disorder3trials
Research institutions
General University Hospital in PragueOpenAlexlinked institution
Institute of ParasitologyOpenAlexlinked institution
University Hospital Hradec KrálovéOpenAlexlinked institution
Czech Society for OrnithologyOpenAlexlinked institution
Masaryk Memorial Cancer InstituteOpenAlexlinked institution
Charles UniversityOpenAlexlinked institution
Institute of Clinical and Experimental MedicineOpenAlexlinked institution
Tomas Bata University in ZlínOpenAlexlinked institution
RECETOXOpenAlexlinked institution
Czech Academy of Sciences, Institute of MicrobiologyOpenAlexlinked institution
Clinical evidence trail
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT07018713A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineRECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RECRUITING
NCT06887192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisRECRUITING
NCT06510816A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)ACTIVE_NOT_RECRUITING
NCT06392386A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia GravisRECRUITING
NCT06290128A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkACTIVE_NOT_RECRUITING
Research evidence trail
PUBMED4-Methylumbelliferone Restores Age-Related Changes in Perineuronal Nets, Memory, and Neuroinflammation.2026-12-01
PUBMEDCaregiver burden and care context in families with Dravet syndrome - a nationwide study in the Czech Republic.2026-11-01
PUBMEDDepression in people with epilepsy: reliability and validity of the Czech version of Beck Depression Inventory (BDI-II) and Beck Depression Fast Screen (BDI-FS) for major depressive episode.2026-11-01
PUBMEDWhen tau goes electric: The first report of a positive correlation between tau burden and ex vivo hyperexcitability in human epileptic hippocampal slices.2026-10-04
PUBMEDDe novo progressive multifocal leukoencephalopathy during ocrelizumab treatment in a patient with primary progressive multiple sclerosis.2026-09-30
PUBMEDCorrection: Remote smartphone-based spoken language screening predicts clinical markers in Huntington's disease.2026-09-28
PUBMEDEffects of Augmented Reality Motor Training on Gait and Balance in Children with Cerebral Palsy: Randomized Controlled Trial.2026-08-29
PUBMEDGut microbiota contributions to anorexia nervosa pathogenesis: insights from the activity-based anorexia model.2026-06-23
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.